Reversing cancer immunoediting phases with a tumor-activated and optically reinforced immunoscaffold.

Authors:
Li X; Liang X; Fu W; Luo R; Zhang M and 7 more

Journal:
Bioact Mater

Publication Year: 2024

DOI:
10.1016/j.bioactmat.2024.01.026

PMCID:
PMC10850754

PMID:
38333614

Journal Information

Full Title: Bioact Mater

Abbreviation: Bioact Mater

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Materials Science, Biomaterials

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work."

Evidence found in paper:

"This work was supported by Funds of Sichuan Province for Distinguished Young Scholar (2021JDJQ0037), the 10.13039/501100001809National Natural Science Foundation of China (82372123), Central Guide Local Science and Technology Development Special Project fund (2023FRD05038), and 1·3·5 project for disciplines of excellence, West China Hospital, Sichuan University (ZYYC23004). Xinchao Li: Writing – original draft, Software, Methodology, Investigation, Conceptualization. Xiuqi Liang: Writing – original draft, Methodology, Investigation, Conceptualization. Wangxian Fu: Writing – original draft, Software, Methodology, Investigation. Rui Luo: Software, Methodology, Investigation. Miaomiao Zhang: Methodology, Investigation. Xiaorong Kou: Methodology, Investigation. Yi Zhang: Methodology, Investigation. Yingjie Li: Investigation. Dongxue Huang: Investigation. Yanjie You: Methodology. Qinjie Wu: Writing – review & editing, Supervision, Funding acquisition, Conceptualization. Changyang Gong: Writing – review & editing, Supervision, Funding acquisition, Conceptualization."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025